1. WHO. Global Tuberculosis Report. https://apps.who.int/iris/bitstream/handle/10665/274453/9789241565646-eng.pdf. (2018).
Accessed 1 Mar 2019.
2. FMOH. National Tuberculosis, Leprosy and Buruli ulcer Management and Control Guidelines.
6th ed. Abuja: NTBLCP 2015.
3. Bam TS, Gunneberg C, Bam D S, Alberg O, Kasland O, Shiyalap K, et al. Factors affecting
patient adherence to DOTs in urban Kathmandu, Nepal. Int J Tuberc Lung Dis. 2006;10(3):270-6.
Accessed 20 June 2010.
4. Bello SI, Itiola O. Drug adherence amongst tuberculosis patients in the University
of Ilorin Teaching Hospital, Ilorin. Nigeria. Afr J Pharmacy and Pharmacology. 2010;4(3):109-14.
Accessed 13 Mar 2012.
5. Erhabor GE, Aghanwa H S, Yusuph M, Adebayo R A, Arogundade F A, Amidiora O. Factors
Influencing compliance in patients with tuberculosis on Directly Observed Therapy
at Ile-Ife, Nigeria. East Afr Med J. 2000;77(5):235-9. Accessed 20 Jun 2010.
6. Kaona FAD, Tuba M, Siziya S, Sikaona L. An assessment of factors contributing to treatment
adherence and knowledge of TB transmission among patients on TB treatment. BMC Public
Health. 2004;4(68). Accessed 20 Jun 2010.
7. Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence to
tuberculosis treatment: A systematic review of qualitative research. PLoS Med. 2007;4(7):238.
8. Sariem CN, Gyang SS, Tayo F, Auta A, Omale S, Ndukwe HC. Factors influencing tuberculosis
medication adherence in a tertiary health institution in Nigeria. West Afr J Pharm.
2013;24(2):66-75.
9. Sariem CN, Nanlir ZS, Banwat SB, Dapar MP. Factors influencing tuberculosis medication
adherence: A cognitive intervention in a resource limited setting. World J Pharm Sci.
2015;3(9):1912-20.
10. Roter DL, Hall A, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions
to improve patient compliance: a meta-analysis. Medical Care. 1998;36:1138–61.
11. Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients follow
prescriptions for medications. The Cochrane Database of Systematic Reviews. 2002(2).
12. Borgdroff MW, Floyd K, Broekmans JF. Intervention to reduce tuberculosis mortality
and transmission in low- and middle-income countries. Bulletin WHO. 2002;80:217-27.
13. Munro S. Theoretical models to support long-term medication adherence in TB and HIV.
3rd International Conference on ARV treatment adherence; NJ, USA. New Jersey: South
African Medical Research Council; 2008.
14. Chisholm-Burns MA, Spivey CA. Pharmacoadherence: A new term for a significant problem.
Am J Health-System Pharm. 2008;65(7):661-7.
15. Dim CC, Dim NR. Trends of tuberculosis prevalence and treatment outcome in an under-resourced
setting: The case of Enugu state, South East Nigeria. NMJ. 2014;54(6):392-7.
16. Ukwaja KN, Alobu I, Ifebunandu NA, Osakwe C, Igwenyi C. Trend in case detection rate
for all tuberculosis cases notified in Ebonyi, Southeastern Nigeria during 1999 –
2009. The Pan Afr Med J. 2013;16(11). Accessed 13 Jul 2017.
17. Fatiregun AA, Ojo AS, Bambgboye AE. Treatment Outcomes amomg pulmonary tuberculosis
patients at treatment centres in Ibadan, Nigeria. Annals Afr Med.2009;8(2):100-4. Accessed 13 Jul 2017.
19. Johansson E, Long NH, Diwan VK, Winkvist A. Gender and tuberculosis control. Health
Policy. 2000;52(1):33-51. Accessed 13 Jul 2017.
20. Weiss MG, Sommerfeld J, Uplekar MW. Social and cultural dimensions of gender and tuberculosis
[Editorial] [Special section on gender and TB]. Int J Tuberc lung Dis. 2008;12(7):829-30.
Accessed 27 Jul 2017.
21. Yassin MA, Datiko DG, Tulloch. O, Markos P, Aschalew M, Shargie EB, et al. Innovative
Community-Based Approaches Doubled Tuberculosis Case Notification and Improve Treatment
Outcome in Southern Ethiopia. PLoS ONE. 2013;8(5).
22. Hamusse SD, Demissie M, Teshome D, Lindtjørn B. Fifteen-year trend in treatment outcomes
among patients with pulmonary smear-positive tuberculosis and its determinants in
Arsi Zone, Central Ethiopia. Glob Health Action. 2014;7(25382):10.
23. Dangisso MH, Datiko DG, Lindtjørn B. Trends of Tuberculosis Case Notification and
Treatment Outcomes in the Sidama Zone, Southern Ethiopia: Ten-Year Retrospective Trend
Analysis in Urban-Rural Settings. PLoS ONE. 2014;9(12).
24. Hamid-Salim MA, Declercq E, Van-Deun A, Saki KAR. Gender differences in tuberculosis:
a prevalence survey done in Bangladesh. Int J Tuberc lung Dis. 2004;8:952-7.
25. Shargie EB, Lindtjørn B. DOTS improves treatment outcomes and service coverage for
tuberculosis in South Ethiopia: a retrospective trend analysis. BMC Public Health.
2005;5(62).
26. Ofoegbu OS, Odume BB. Treatment outcome of tuberculosis patients at National Hospital
Abuja Nigeria: a five year retrospective study. South Afri Fam Pract. 2015;57(1):50-6.
27. Sariem CN, Ndukwe HC, Dayom WD. Assessing the effectiveness of Directly Observed Therapy
short-course (DOTs) for tuberculosis in a Nigerian hospital. J Pharm Biores. 2012;9(2):116-21.
28. MacLehose HG. Improving practice using systematic reviews: A series about evidence-based
practice. Afri Health. 2002;11-7.
29. Lienhardt C, Manneh K, Bonchier V, Lahai G, Millian PJ, McAdam KP. Factors determining
the outcome of treatment of adult smear positive tuberculosis cases in the Gambia.
Int J Tuberc Lung Dis. 1998;2:712-8.
30. Johnson HD, Dayalan M R, Wei CC, Kasinathan G, Navarathnam P, Pillai N. Predictors
of Tuberculosis Treatment Outcome in an Urban Setting: A Retrospective Cohort Study.
Am J Infec Dis Microbiol. 2016;4(1):14-21. Accessed 13 Jul 2017